- Investing Ideas
- /
- Singaporean Pharmaceuticals & Biotech Financially Fit Penny Stocks
Singaporean Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
2
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
2 companies
Hyphens Pharma International
Market Cap: S$109.6m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.35
7D
-5.3%
1Y
22.4%
Pharmesis International
Market Cap: S$14.4m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.46
7D
0%
1Y
261.1%